

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.65347532 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.65347532 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 6.24721311 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.44954280 |
| 5 | fucose catabolic process (GO:0019317) | 4.83175524 |
| 6 | L-fucose metabolic process (GO:0042354) | 4.83175524 |
| 7 | L-fucose catabolic process (GO:0042355) | 4.83175524 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.75918807 |
| 9 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.73453960 |
| 10 | negative thymic T cell selection (GO:0045060) | 4.71914102 |
| 11 | DNA deamination (GO:0045006) | 4.66863474 |
| 12 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.63041508 |
| 13 | negative T cell selection (GO:0043383) | 4.60386701 |
| 14 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.55192413 |
| 15 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.54162044 |
| 16 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.41919461 |
| 17 | regulation of T cell tolerance induction (GO:0002664) | 4.09049177 |
| 18 | cellular response to type I interferon (GO:0071357) | 4.06840329 |
| 19 | type I interferon signaling pathway (GO:0060337) | 4.06840329 |
| 20 | response to type I interferon (GO:0034340) | 4.05631590 |
| 21 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.93592945 |
| 22 | regulation of activation of Janus kinase activity (GO:0010533) | 3.92896216 |
| 23 | behavioral response to nicotine (GO:0035095) | 3.92597483 |
| 24 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.79459160 |
| 25 | tryptophan catabolic process (GO:0006569) | 3.78214404 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 3.78214404 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 3.78214404 |
| 28 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.71905775 |
| 29 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.66746721 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.65554017 |
| 31 | rRNA catabolic process (GO:0016075) | 3.65022351 |
| 32 | regulation of hypersensitivity (GO:0002883) | 3.61890056 |
| 33 | regulation of natural killer cell differentiation (GO:0032823) | 3.58514532 |
| 34 | T-helper 1 type immune response (GO:0042088) | 3.55916036 |
| 35 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.55567877 |
| 36 | leukocyte aggregation (GO:0070486) | 3.55474863 |
| 37 | response to interleukin-15 (GO:0070672) | 3.54794349 |
| 38 | regulation of RIG-I signaling pathway (GO:0039535) | 3.53220591 |
| 39 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 3.51468178 |
| 40 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 3.51468178 |
| 41 | regulation of translation, ncRNA-mediated (GO:0045974) | 3.51468178 |
| 42 | positive regulation of interleukin-2 production (GO:0032743) | 3.50922194 |
| 43 | tryptophan metabolic process (GO:0006568) | 3.49850291 |
| 44 | response to pheromone (GO:0019236) | 3.49099783 |
| 45 | thymic T cell selection (GO:0045061) | 3.47659152 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 3.47302514 |
| 47 | natural killer cell differentiation (GO:0001779) | 3.46925472 |
| 48 | regulation of gamma-delta T cell activation (GO:0046643) | 3.45796115 |
| 49 | T cell costimulation (GO:0031295) | 3.43765290 |
| 50 | positive regulation of interferon-alpha production (GO:0032727) | 3.43535957 |
| 51 | T cell selection (GO:0045058) | 3.42722164 |
| 52 | indolalkylamine metabolic process (GO:0006586) | 3.41556617 |
| 53 | positive regulation of interleukin-12 production (GO:0032735) | 3.40438737 |
| 54 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.38524772 |
| 55 | interferon-gamma production (GO:0032609) | 3.38435018 |
| 56 | lymphocyte costimulation (GO:0031294) | 3.37853554 |
| 57 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.37838765 |
| 58 | neural tube formation (GO:0001841) | 3.37394112 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 3.34625072 |
| 60 | positive thymic T cell selection (GO:0045059) | 3.31557427 |
| 61 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.31163031 |
| 62 | T cell migration (GO:0072678) | 3.29457076 |
| 63 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.28083476 |
| 64 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.27220218 |
| 65 | detection of light stimulus involved in visual perception (GO:0050908) | 3.27220218 |
| 66 | regulation of interferon-alpha production (GO:0032647) | 3.24994455 |
| 67 | kynurenine metabolic process (GO:0070189) | 3.24623070 |
| 68 | natural killer cell mediated immunity (GO:0002228) | 3.24264349 |
| 69 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.24264349 |
| 70 | positive regulation of humoral immune response (GO:0002922) | 3.24256378 |
| 71 | regulation of T-helper cell differentiation (GO:0045622) | 3.24126754 |
| 72 | natural killer cell activation (GO:0030101) | 3.23054624 |
| 73 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 3.22978966 |
| 74 | regulation of tolerance induction (GO:0002643) | 3.21964097 |
| 75 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.21519639 |
| 76 | positive regulation of B cell differentiation (GO:0045579) | 3.18785179 |
| 77 | positive regulation of isotype switching (GO:0045830) | 3.18212955 |
| 78 | positive regulation of T cell cytokine production (GO:0002726) | 3.17824729 |
| 79 | positive regulation of interleukin-17 production (GO:0032740) | 3.16289167 |
| 80 | cellular response to zinc ion (GO:0071294) | 3.13252669 |
| 81 | regulation of T-helper 1 type immune response (GO:0002825) | 3.12389564 |
| 82 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.11959482 |
| 83 | regulation of memory T cell differentiation (GO:0043380) | 3.10506040 |
| 84 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.10480100 |
| 85 | defense response to protozoan (GO:0042832) | 3.09847334 |
| 86 | myeloid dendritic cell differentiation (GO:0043011) | 3.09409362 |
| 87 | positive regulation of antigen processing and presentation (GO:0002579) | 3.09121876 |
| 88 | myeloid dendritic cell activation (GO:0001773) | 3.09026179 |
| 89 | regulation of B cell differentiation (GO:0045577) | 3.06668994 |
| 90 | protein K11-linked deubiquitination (GO:0035871) | 3.04131993 |
| 91 | positive regulation of defense response to virus by host (GO:0002230) | 3.04045370 |
| 92 | ketone body metabolic process (GO:1902224) | 3.03237126 |
| 93 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.02958324 |
| 94 | cellular response to interleukin-15 (GO:0071350) | 3.00964357 |
| 95 | cytidine deamination (GO:0009972) | 3.00726663 |
| 96 | cytidine metabolic process (GO:0046087) | 3.00726663 |
| 97 | cytidine catabolic process (GO:0006216) | 3.00726663 |
| 98 | regulation of natural killer cell activation (GO:0032814) | 2.98650860 |
| 99 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.98608280 |
| 100 | double-strand break repair via homologous recombination (GO:0000724) | 2.97651566 |
| 101 | recombinational repair (GO:0000725) | 2.96631709 |
| 102 | replication fork processing (GO:0031297) | 2.93039860 |
| 103 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.92415490 |
| 104 | neutrophil activation involved in immune response (GO:0002283) | 2.91435135 |
| 105 | positive regulation of T-helper 1 type immune response (GO:0002827) | 2.90978237 |
| 106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.90614620 |
| 107 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.90531376 |
| 108 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 2.90531376 |
| 109 | immunoglobulin mediated immune response (GO:0016064) | 2.90423895 |
| 110 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.89972906 |
| 111 | negative regulation of cell killing (GO:0031342) | 2.89972906 |
| 112 | regulation of immunoglobulin secretion (GO:0051023) | 2.89597484 |
| 113 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.88539783 |
| 114 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.88539783 |
| 115 | positive regulation of activated T cell proliferation (GO:0042104) | 2.88137893 |
| 116 | positive regulation of inflammatory response to antigenic stimulus (GO:0002863) | 2.88019583 |
| 117 | positive regulation of alpha-beta T cell differentiation (GO:0046638) | 2.87652794 |
| 118 | regulation of interleukin-12 production (GO:0032655) | 2.87451182 |
| 119 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.86266335 |
| 120 | positive regulation of lamellipodium assembly (GO:0010592) | 2.85877263 |
| 121 | amine catabolic process (GO:0009310) | 2.85810386 |
| 122 | cellular biogenic amine catabolic process (GO:0042402) | 2.85810386 |
| 123 | platelet dense granule organization (GO:0060155) | 2.85769768 |
| 124 | negative regulation of telomere maintenance (GO:0032205) | 2.85697530 |
| 125 | positive regulation of T cell proliferation (GO:0042102) | 2.84431164 |
| 126 | regulation of interleukin-17 production (GO:0032660) | 2.84354934 |
| 127 | response to protozoan (GO:0001562) | 2.84262379 |
| 128 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.81095177 |
| 129 | negative regulation of interleukin-17 production (GO:0032700) | 2.80941657 |
| 130 | reciprocal DNA recombination (GO:0035825) | 2.80163929 |
| 131 | reciprocal meiotic recombination (GO:0007131) | 2.80163929 |
| 132 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.78922042 |
| 133 | positive regulation of alpha-beta T cell activation (GO:0046635) | 2.78746606 |
| 134 | regulation of response to interferon-gamma (GO:0060330) | 2.78701877 |
| 135 | positive regulation of mRNA catabolic process (GO:0061014) | 2.75852126 |
| 136 | response to interferon-alpha (GO:0035455) | 2.75391977 |
| 137 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.75198061 |
| 138 | positive regulation of natural killer cell activation (GO:0032816) | 2.74802499 |
| 139 | activated T cell proliferation (GO:0050798) | 2.74800779 |
| 140 | regulation of immune response to tumor cell (GO:0002837) | 2.74717851 |
| 141 | positive regulation of response to tumor cell (GO:0002836) | 2.74717851 |
| 142 | regulation of glucokinase activity (GO:0033131) | 2.73309167 |
| 143 | regulation of hexokinase activity (GO:1903299) | 2.73309167 |
| 144 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.72332874 |
| 145 | mast cell activation involved in immune response (GO:0002279) | 2.72005234 |
| 146 | mast cell degranulation (GO:0043303) | 2.72005234 |
| 147 | signal peptide processing (GO:0006465) | 2.69062032 |
| 148 | B cell receptor signaling pathway (GO:0050853) | 2.68027970 |
| 149 | NAD biosynthetic process (GO:0009435) | 2.65345566 |
| 150 | photoreceptor cell maintenance (GO:0045494) | 2.64090437 |
| 151 | kidney morphogenesis (GO:0060993) | 2.64087108 |
| 152 | DNA demethylation (GO:0080111) | 2.63546810 |
| 153 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.58509717 |
| 154 | positive regulation of developmental pigmentation (GO:0048087) | 2.57869242 |
| 155 | cellular response to exogenous dsRNA (GO:0071360) | 2.57177877 |
| 156 | centriole replication (GO:0007099) | 2.54467240 |
| 157 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 2.54162422 |
| 158 | negative regulation of mast cell activation (GO:0033004) | 2.50823220 |
| 159 | axoneme assembly (GO:0035082) | 2.47678222 |
| 160 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.46245523 |
| 161 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.46245523 |
| 162 | fucosylation (GO:0036065) | 2.46227212 |
| 163 | cell wall macromolecule catabolic process (GO:0016998) | 2.44990060 |
| 164 | prenylation (GO:0097354) | 2.44911912 |
| 165 | protein prenylation (GO:0018342) | 2.44911912 |
| 166 | histone mRNA catabolic process (GO:0071044) | 2.44889731 |
| 167 | piRNA metabolic process (GO:0034587) | 2.44450161 |
| 168 | epithelial cilium movement (GO:0003351) | 2.43171928 |
| 169 | dopamine transport (GO:0015872) | 2.39202193 |
| 170 | interkinetic nuclear migration (GO:0022027) | 2.38287923 |
| 171 | respiratory chain complex IV assembly (GO:0008535) | 2.38133699 |
| 172 | positive regulation of fatty acid transport (GO:2000193) | 2.37875892 |
| 173 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.37185131 |
| 174 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.36880758 |
| 175 | positive regulation of granulocyte differentiation (GO:0030854) | 2.36666060 |
| 176 | phosphatidylinositol acyl-chain remodeling (GO:0036149) | 2.34896704 |
| 177 | protein-cofactor linkage (GO:0018065) | 2.34617047 |
| 178 | DNA methylation involved in gamete generation (GO:0043046) | 2.34065102 |
| 179 | regulation of telomere maintenance (GO:0032204) | 2.32407910 |
| 180 | indole-containing compound metabolic process (GO:0042430) | 2.32233556 |
| 181 | histone H3-K9 methylation (GO:0051567) | 2.31429897 |
| 182 | ncRNA catabolic process (GO:0034661) | 2.30423015 |
| 183 | mast cell activation (GO:0045576) | 2.28288176 |
| 184 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.28085445 |
| 185 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.27568766 |
| 186 | DNA double-strand break processing (GO:0000729) | 2.26007762 |
| 187 | mannosylation (GO:0097502) | 2.25842225 |
| 188 | regulation of mRNA catabolic process (GO:0061013) | 2.25742691 |
| 189 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.25322539 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.86507543 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.07723175 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.90697186 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.42094090 |
| 5 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.28119179 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.21718303 |
| 7 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.64810932 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.34773494 |
| 9 | VDR_22108803_ChIP-Seq_LS180_Human | 3.03008344 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.97577805 |
| 11 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 2.93551284 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.89642943 |
| 13 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.87664606 |
| 14 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.82716066 |
| 15 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.77779596 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.68723594 |
| 17 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.64882072 |
| 18 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.62980223 |
| 19 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.59369505 |
| 20 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54099931 |
| 21 | MYB_26560356_Chip-Seq_TH2_Human | 2.48856570 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.46065287 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.43941395 |
| 24 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.40523315 |
| 25 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.40215758 |
| 26 | * MAF_26560356_Chip-Seq_TH1_Human | 2.38486698 |
| 27 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28573992 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.21903943 |
| 29 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.21511630 |
| 30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.20395011 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16696164 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 2.15652324 |
| 33 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.12937351 |
| 34 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.12225944 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.10042592 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.09051039 |
| 37 | EWS_26573619_Chip-Seq_HEK293_Human | 2.03382662 |
| 38 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.03089055 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.01012591 |
| 40 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.96265321 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.95102070 |
| 42 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.93204663 |
| 43 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.91203278 |
| 44 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90509680 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.89596607 |
| 46 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.86807588 |
| 47 | MYC_22102868_ChIP-Seq_BL_Human | 1.85685202 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.83938706 |
| 49 | UTX_26944678_Chip-Seq_JUKART_Human | 1.83593217 |
| 50 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.83508767 |
| 51 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.83045427 |
| 52 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.82283246 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.81779183 |
| 54 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.80434009 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.79625563 |
| 56 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.79416433 |
| 57 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.77763080 |
| 58 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76849487 |
| 59 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75660013 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.74846394 |
| 61 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.72994781 |
| 62 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.66410318 |
| 63 | P300_19829295_ChIP-Seq_ESCs_Human | 1.65447754 |
| 64 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.64204163 |
| 65 | FUS_26573619_Chip-Seq_HEK293_Human | 1.63030592 |
| 66 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62429383 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.60489311 |
| 68 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.58943136 |
| 69 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.57894192 |
| 70 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.57027945 |
| 71 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.55087163 |
| 72 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.54641771 |
| 73 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.53962690 |
| 74 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.53437264 |
| 75 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.52429287 |
| 76 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.49968914 |
| 77 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49017764 |
| 78 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47432746 |
| 79 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.47147586 |
| 80 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.45936094 |
| 81 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.45642841 |
| 82 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.45234589 |
| 83 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.43333938 |
| 84 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.42518932 |
| 85 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.40227993 |
| 86 | MAF_26560356_Chip-Seq_TH2_Human | 1.40059596 |
| 87 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40020929 |
| 88 | TCF4_23295773_ChIP-Seq_U87_Human | 1.39343008 |
| 89 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.39050724 |
| 90 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.38970225 |
| 91 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.37242248 |
| 92 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.34583608 |
| 93 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.33819612 |
| 94 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.32917715 |
| 95 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.32765780 |
| 96 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.32170028 |
| 97 | GATA3_26560356_Chip-Seq_TH2_Human | 1.30673818 |
| 98 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.30376166 |
| 99 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.29603975 |
| 100 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.28618733 |
| 101 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28375114 |
| 102 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.28296667 |
| 103 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.27676364 |
| 104 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.27625781 |
| 105 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.26710842 |
| 106 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.26659231 |
| 107 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.26564980 |
| 108 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.26564980 |
| 109 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.25149387 |
| 110 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.25149387 |
| 111 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.24670274 |
| 112 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.24670274 |
| 113 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.24065008 |
| 114 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23807449 |
| 115 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23542528 |
| 116 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.22962890 |
| 117 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.21844380 |
| 118 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.20120187 |
| 119 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.19941823 |
| 120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.19360093 |
| 121 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17734635 |
| 122 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.16975890 |
| 123 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.16712444 |
| 124 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.16712444 |
| 125 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.15073528 |
| 126 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.15065534 |
| 127 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14993918 |
| 128 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13813187 |
| 129 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.11770089 |
| 130 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.10935722 |
| 131 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.10699076 |
| 132 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.10475494 |
| 133 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10348473 |
| 134 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10102811 |
| 135 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09820033 |
| 136 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.09817257 |
| 137 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.09329800 |
| 138 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08976449 |
| 139 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.08750611 |
| 140 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.08323443 |
| 141 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.07386753 |
| 142 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.06472141 |
| 143 | SMRT_27268052_Chip-Seq_Bcells_Human | 1.06404754 |
| 144 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.06286409 |
| 145 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.05002463 |
| 146 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03260479 |
| 147 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.02655472 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.02543003 |
| 149 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.02495689 |
| 150 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.02250714 |
| 151 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.00792564 |
| 152 | NCOR_22424771_ChIP-Seq_293T_Human | 1.00667265 |
| 153 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00090933 |
| 154 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99426600 |
| 155 | HOXB7_26014856_ChIP-Seq_BT474_Human | 0.98591690 |
| 156 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97924413 |
| 157 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.97538005 |
| 158 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.96885229 |
| 159 | GATA3_26560356_Chip-Seq_TH1_Human | 0.96709674 |
| 160 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.96076203 |
| 161 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95568749 |
| 162 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.95307809 |
| 163 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95120653 |
| 164 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.94669454 |
| 165 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93845546 |
| 166 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.93417777 |
| 167 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93001643 |
| 168 | GATA2_19941826_ChIP-Seq_K562_Human | 0.92650670 |
| 169 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.92145403 |
| 170 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.88273085 |
| 171 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.87257659 |
| 172 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.86712110 |
| 173 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.86293220 |
| 174 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85067338 |
| 175 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.82337869 |
| 176 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.82219754 |
| 177 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.81310198 |
| 178 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81149429 |
| 179 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.79854826 |
| 180 | * NCOR1_26117541_ChIP-Seq_K562_Human | 0.74179217 |
| 181 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.73415525 |
| 182 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.73061085 |
| 183 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.71109277 |
| 184 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.71077732 |
| 185 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.70558857 |
| 186 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.69141609 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.72608666 |
| 2 | MP0000685_abnormal_immune_system | 4.12603561 |
| 3 | MP0005671_abnormal_response_to | 3.63741800 |
| 4 | MP0009785_altered_susceptibility_to | 3.29962354 |
| 5 | MP0001790_abnormal_immune_system | 3.16397210 |
| 6 | MP0005387_immune_system_phenotype | 3.16397210 |
| 7 | MP0008877_abnormal_DNA_methylation | 3.06850396 |
| 8 | MP0000569_abnormal_digit_pigmentation | 2.74291654 |
| 9 | MP0003787_abnormal_imprinting | 2.69074603 |
| 10 | MP0001800_abnormal_humoral_immune | 2.65698030 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.65464471 |
| 12 | MP0003436_decreased_susceptibility_to | 2.65019889 |
| 13 | MP0003195_calcinosis | 2.61541134 |
| 14 | MP0005025_abnormal_response_to | 2.60914839 |
| 15 | MP0003763_abnormal_thymus_physiology | 2.58162834 |
| 16 | MP0002148_abnormal_hypersensitivity_rea | 2.54511772 |
| 17 | MP0002723_abnormal_immune_serum | 2.44482440 |
| 18 | MP0002166_altered_tumor_susceptibility | 2.42004500 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.32969602 |
| 20 | MP0001819_abnormal_immune_cell | 2.30511733 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.29059094 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 2.25646269 |
| 23 | MP0003724_increased_susceptibility_to | 2.25433428 |
| 24 | MP0006082_CNS_inflammation | 2.22229738 |
| 25 | MP0002419_abnormal_innate_immunity | 2.14208511 |
| 26 | MP0002398_abnormal_bone_marrow | 2.13796965 |
| 27 | MP0005360_urolithiasis | 2.11686642 |
| 28 | MP0001986_abnormal_taste_sensitivity | 2.10120127 |
| 29 | MP0008057_abnormal_DNA_replication | 2.05904261 |
| 30 | MP0003646_muscle_fatigue | 2.04108906 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.96363023 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.95615371 |
| 33 | MP0000716_abnormal_immune_system | 1.94833763 |
| 34 | MP0002006_tumorigenesis | 1.89493440 |
| 35 | MP0010155_abnormal_intestine_physiology | 1.89036213 |
| 36 | MP0005551_abnormal_eye_electrophysiolog | 1.88906449 |
| 37 | MP0002396_abnormal_hematopoietic_system | 1.88498492 |
| 38 | MP0009840_abnormal_foam_cell | 1.87657009 |
| 39 | MP0002405_respiratory_system_inflammati | 1.86268684 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.84619146 |
| 41 | MP0004947_skin_inflammation | 1.83207961 |
| 42 | MP0001968_abnormal_touch/_nociception | 1.77734547 |
| 43 | MP0002102_abnormal_ear_morphology | 1.77179035 |
| 44 | MP0001873_stomach_inflammation | 1.72634090 |
| 45 | MP0003300_gastrointestinal_ulcer | 1.70961630 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.69853331 |
| 47 | MP0002722_abnormal_immune_system | 1.69390661 |
| 48 | MP0000689_abnormal_spleen_morphology | 1.68784629 |
| 49 | MP0001853_heart_inflammation | 1.66390626 |
| 50 | MP0002429_abnormal_blood_cell | 1.65467263 |
| 51 | MP0000372_irregular_coat_pigmentation | 1.64023670 |
| 52 | MP0002139_abnormal_hepatobiliary_system | 1.63485719 |
| 53 | MP0005310_abnormal_salivary_gland | 1.58195634 |
| 54 | MP0008469_abnormal_protein_level | 1.58081218 |
| 55 | MP0002837_dystrophic_cardiac_calcinosis | 1.56961815 |
| 56 | MP0008058_abnormal_DNA_repair | 1.56569511 |
| 57 | MP0005253_abnormal_eye_physiology | 1.56183900 |
| 58 | MP0001348_abnormal_lacrimal_gland | 1.52551054 |
| 59 | MP0003191_abnormal_cellular_cholesterol | 1.50775036 |
| 60 | MP0003252_abnormal_bile_duct | 1.50080708 |
| 61 | MP0004043_abnormal_pH_regulation | 1.49882707 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.49577245 |
| 63 | MP0004510_myositis | 1.48676040 |
| 64 | MP0004142_abnormal_muscle_tone | 1.48549944 |
| 65 | MP0009046_muscle_twitch | 1.46893171 |
| 66 | MP0008872_abnormal_physiological_respon | 1.46710862 |
| 67 | MP0009764_decreased_sensitivity_to | 1.46413819 |
| 68 | MP0009333_abnormal_splenocyte_physiolog | 1.44229677 |
| 69 | MP0001501_abnormal_sleep_pattern | 1.44081998 |
| 70 | MP0005365_abnormal_bile_salt | 1.42276940 |
| 71 | MP0003866_abnormal_defecation | 1.40370831 |
| 72 | MP0003656_abnormal_erythrocyte_physiolo | 1.38994013 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.36786541 |
| 74 | MP0005397_hematopoietic_system_phenotyp | 1.36693584 |
| 75 | MP0001545_abnormal_hematopoietic_system | 1.36693584 |
| 76 | MP0000703_abnormal_thymus_morphology | 1.35907472 |
| 77 | MP0006292_abnormal_olfactory_placode | 1.35849451 |
| 78 | MP0002876_abnormal_thyroid_physiology | 1.34835527 |
| 79 | MP0003303_peritoneal_inflammation | 1.34624937 |
| 80 | MP0002638_abnormal_pupillary_reflex | 1.33853638 |
| 81 | MP0002736_abnormal_nociception_after | 1.33585758 |
| 82 | MP0001533_abnormal_skeleton_physiology | 1.32308825 |
| 83 | MP0000015_abnormal_ear_pigmentation | 1.30512555 |
| 84 | MP0010352_gastrointestinal_tract_polyps | 1.29141181 |
| 85 | MP0008875_abnormal_xenobiotic_pharmacok | 1.28676464 |
| 86 | MP0003172_abnormal_lysosome_physiology | 1.22466717 |
| 87 | MP0005084_abnormal_gallbladder_morpholo | 1.22016673 |
| 88 | MP0009763_increased_sensitivity_to | 1.16699526 |
| 89 | MP0009745_abnormal_behavioral_response | 1.15804834 |
| 90 | MP0008995_early_reproductive_senescence | 1.14822153 |
| 91 | MP0000858_altered_metastatic_potential | 1.10909963 |
| 92 | MP0004885_abnormal_endolymph | 1.10191044 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 1.08755560 |
| 94 | MP0005167_abnormal_blood-brain_barrier | 1.08131064 |
| 95 | MP0000609_abnormal_liver_physiology | 1.08066726 |
| 96 | MP0010094_abnormal_chromosome_stability | 1.06938977 |
| 97 | MP0004808_abnormal_hematopoietic_stem | 1.05074070 |
| 98 | MP0002095_abnormal_skin_pigmentation | 1.04709625 |
| 99 | MP0000604_amyloidosis | 1.03089631 |
| 100 | MP0002693_abnormal_pancreas_physiology | 1.03063239 |
| 101 | MP0000427_abnormal_hair_cycle | 1.02470820 |
| 102 | MP0010329_abnormal_lipoprotein_level | 1.02243540 |
| 103 | MP0001485_abnormal_pinna_reflex | 1.00646530 |
| 104 | MP0005083_abnormal_biliary_tract | 0.99778997 |
| 105 | MP0003448_altered_tumor_morphology | 0.99069171 |
| 106 | MP0005646_abnormal_pituitary_gland | 0.98797425 |
| 107 | MP0004782_abnormal_surfactant_physiolog | 0.97305588 |
| 108 | MP0003136_yellow_coat_color | 0.96669623 |
| 109 | MP0010307_abnormal_tumor_latency | 0.96482509 |
| 110 | MP0009765_abnormal_xenobiotic_induced | 0.95159200 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.94937695 |
| 112 | MP0006276_abnormal_autonomic_nervous | 0.94642826 |
| 113 | MP0002272_abnormal_nervous_system | 0.94518096 |
| 114 | MP0003718_maternal_effect | 0.93465645 |
| 115 | MP0003786_premature_aging | 0.93245128 |
| 116 | MP0004147_increased_porphyrin_level | 0.91593408 |
| 117 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.91056602 |
| 118 | MP0002733_abnormal_thermal_nociception | 0.90746563 |
| 119 | MP0006035_abnormal_mitochondrial_morpho | 0.89002634 |
| 120 | MP0001666_abnormal_nutrient_absorption | 0.88835018 |
| 121 | MP0002933_joint_inflammation | 0.87867839 |
| 122 | MP0004924_abnormal_behavior | 0.87701602 |
| 123 | MP0005386_behavior/neurological_phenoty | 0.87701602 |
| 124 | MP0005379_endocrine/exocrine_gland_phen | 0.87676167 |
| 125 | MP0002254_reproductive_system_inflammat | 0.87645013 |
| 126 | MP0003806_abnormal_nucleotide_metabolis | 0.87366451 |
| 127 | MP0003045_fibrosis | 0.87327274 |
| 128 | MP0009643_abnormal_urine_homeostasis | 0.87243847 |
| 129 | MP0002163_abnormal_gland_morphology | 0.86230031 |
| 130 | MP0002653_abnormal_ependyma_morphology | 0.84583538 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.84098422 |
| 132 | MP0001984_abnormal_olfaction | 0.83885259 |
| 133 | MP0005389_reproductive_system_phenotype | 0.83746296 |
| 134 | MP0000490_abnormal_crypts_of | 0.82888466 |
| 135 | MP0003183_abnormal_peptide_metabolism | 0.82640099 |
| 136 | MP0005319_abnormal_enzyme/_coenzyme | 0.82564068 |
| 137 | MP0003186_abnormal_redox_activity | 0.82436040 |
| 138 | MP0000465_gastrointestinal_hemorrhage | 0.81679164 |
| 139 | MP0002019_abnormal_tumor_incidence | 0.81473021 |
| 140 | MP0008775_abnormal_heart_ventricle | 0.81437665 |
| 141 | MP0005332_abnormal_amino_acid | 0.81327609 |
| 142 | MP0000230_abnormal_systemic_arterial | 0.79104242 |
| 143 | MP0000631_abnormal_neuroendocrine_gland | 0.78089850 |
| 144 | MP0002136_abnormal_kidney_physiology | 0.77683512 |
| 145 | MP0000343_altered_response_to | 0.77007254 |
| 146 | MP0000598_abnormal_liver_morphology | 0.75813093 |
| 147 | MP0001970_abnormal_pain_threshold | 0.75754196 |
| 148 | MP0002067_abnormal_sensory_capabilities | 0.73533409 |
| 149 | MP0000371_diluted_coat_color | 0.73353672 |
| 150 | MP0005377_hearing/vestibular/ear_phenot | 0.72174250 |
| 151 | MP0003878_abnormal_ear_physiology | 0.72174250 |
| 152 | MP0000383_abnormal_hair_follicle | 0.71476019 |
| 153 | MP0010234_abnormal_vibrissa_follicle | 0.69354950 |
| 154 | MP0003075_altered_response_to | 0.67107127 |
| 155 | MP0002132_abnormal_respiratory_system | 0.64713651 |
| 156 | MP0001881_abnormal_mammary_gland | 0.64300744 |
| 157 | MP0005075_abnormal_melanosome_morpholog | 0.63991440 |
| 158 | MP0000249_abnormal_blood_vessel | 0.62612280 |
| 159 | MP0001346_abnormal_lacrimal_gland | 0.62571659 |
| 160 | MP0005076_abnormal_cell_differentiation | 0.62354376 |
| 161 | MP0009278_abnormal_bone_marrow | 0.61792184 |
| 162 | MP0005023_abnormal_wound_healing | 0.61775503 |
| 163 | MP0002998_abnormal_bone_remodeling | 0.61338130 |
| 164 | MP0002928_abnormal_bile_duct | 0.60310857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Chronic otitis media (HP:0000389) | 5.04356317 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.71142292 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.54620300 |
| 4 | Pancreatic cysts (HP:0001737) | 4.45974892 |
| 5 | Myositis (HP:0100614) | 4.42694432 |
| 6 | Increased IgM level (HP:0003496) | 4.40181961 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.07058532 |
| 8 | Pancreatic fibrosis (HP:0100732) | 3.92891833 |
| 9 | Recurrent viral infections (HP:0004429) | 3.87210246 |
| 10 | Recurrent abscess formation (HP:0002722) | 3.78407737 |
| 11 | Nasal polyposis (HP:0100582) | 3.74815575 |
| 12 | Autoimmune thrombocytopenia (HP:0001973) | 3.74474084 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 3.72456146 |
| 14 | Congenital stationary night blindness (HP:0007642) | 3.69991699 |
| 15 | Abnormality of T cell number (HP:0011839) | 3.68500800 |
| 16 | Recurrent bronchitis (HP:0002837) | 3.66556131 |
| 17 | Orchitis (HP:0100796) | 3.65382590 |
| 18 | Optic neuritis (HP:0100653) | 3.63819293 |
| 19 | Retrobulbar optic neuritis (HP:0100654) | 3.63819293 |
| 20 | Stomatitis (HP:0010280) | 3.58869915 |
| 21 | Abnormality of midbrain morphology (HP:0002418) | 3.52980447 |
| 22 | Molar tooth sign on MRI (HP:0002419) | 3.52980447 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.48923067 |
| 24 | T lymphocytopenia (HP:0005403) | 3.47368166 |
| 25 | Nephronophthisis (HP:0000090) | 3.46666216 |
| 26 | True hermaphroditism (HP:0010459) | 3.45114406 |
| 27 | Gastrointestinal infarctions (HP:0005244) | 3.44685084 |
| 28 | Abnormality of the renal cortex (HP:0011035) | 3.42337662 |
| 29 | IgG deficiency (HP:0004315) | 3.40659787 |
| 30 | Abnormality of T cells (HP:0002843) | 3.38966713 |
| 31 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31571966 |
| 32 | Abnormality of T cell physiology (HP:0011840) | 3.30638256 |
| 33 | Hypergammaglobulinemia (HP:0010702) | 3.28049959 |
| 34 | Vasculitis (HP:0002633) | 3.27918888 |
| 35 | Recurrent cutaneous fungal infections (HP:0011370) | 3.22235231 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.22235231 |
| 37 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.17489994 |
| 38 | Abnormality of the renal medulla (HP:0100957) | 3.15843792 |
| 39 | Recurrent skin infections (HP:0001581) | 3.14197879 |
| 40 | Autoimmune hemolytic anemia (HP:0001890) | 3.09342171 |
| 41 | Interstitial pulmonary disease (HP:0006530) | 3.08397325 |
| 42 | Gingival bleeding (HP:0000225) | 3.07111503 |
| 43 | Attenuation of retinal blood vessels (HP:0007843) | 3.06080967 |
| 44 | Panhypogammaglobulinemia (HP:0003139) | 3.02907534 |
| 45 | Abnormality of macrophages (HP:0004311) | 3.02643810 |
| 46 | Chronic diarrhea (HP:0002028) | 3.01380493 |
| 47 | IgM deficiency (HP:0002850) | 2.92175298 |
| 48 | Chronic hepatic failure (HP:0100626) | 2.89088676 |
| 49 | Arterial thrombosis (HP:0004420) | 2.88484200 |
| 50 | Severe combined immunodeficiency (HP:0004430) | 2.84690164 |
| 51 | Gaze-evoked nystagmus (HP:0000640) | 2.83766425 |
| 52 | Tubular atrophy (HP:0000092) | 2.82269106 |
| 53 | IgA deficiency (HP:0002720) | 2.78325988 |
| 54 | Mediastinal lymphadenopathy (HP:0100721) | 2.77976424 |
| 55 | Hyperventilation (HP:0002883) | 2.75294812 |
| 56 | Hypoplasia of the thymus (HP:0000778) | 2.74501109 |
| 57 | Abnormality of the fingertips (HP:0001211) | 2.73210094 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.71918004 |
| 59 | Abolished electroretinogram (ERG) (HP:0000550) | 2.71735346 |
| 60 | Abnormal biliary tract physiology (HP:0012439) | 2.71627721 |
| 61 | Bile duct proliferation (HP:0001408) | 2.71627721 |
| 62 | Joint swelling (HP:0001386) | 2.71617983 |
| 63 | Cystic liver disease (HP:0006706) | 2.70601438 |
| 64 | Combined immunodeficiency (HP:0005387) | 2.70368076 |
| 65 | Hemoptysis (HP:0002105) | 2.69738069 |
| 66 | Leukocytosis (HP:0001974) | 2.69273416 |
| 67 | Thrombocytosis (HP:0001894) | 2.69107818 |
| 68 | Encephalitis (HP:0002383) | 2.67472817 |
| 69 | Gingivitis (HP:0000230) | 2.66843709 |
| 70 | Petechiae (HP:0000967) | 2.66716707 |
| 71 | Abnormality of eosinophils (HP:0001879) | 2.61291723 |
| 72 | Epistaxis (HP:0000421) | 2.61145581 |
| 73 | Meningitis (HP:0001287) | 2.61032927 |
| 74 | Eosinophilia (HP:0001880) | 2.60613610 |
| 75 | Increased IgE level (HP:0003212) | 2.60493113 |
| 76 | Keratoconjunctivitis sicca (HP:0001097) | 2.59913997 |
| 77 | Protruding tongue (HP:0010808) | 2.59199769 |
| 78 | Polydipsia (HP:0001959) | 2.59052287 |
| 79 | Abnormal drinking behavior (HP:0030082) | 2.59052287 |
| 80 | Pustule (HP:0200039) | 2.56709096 |
| 81 | Spontaneous hematomas (HP:0007420) | 2.56545746 |
| 82 | Anorexia (HP:0002039) | 2.46895474 |
| 83 | Keratoconjunctivitis (HP:0001096) | 2.45302889 |
| 84 | Genetic anticipation (HP:0003743) | 2.44557539 |
| 85 | Medial flaring of the eyebrow (HP:0010747) | 2.43587897 |
| 86 | Granulocytopenia (HP:0001913) | 2.41500396 |
| 87 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.41046028 |
| 88 | Agammaglobulinemia (HP:0004432) | 2.39689220 |
| 89 | Type II lissencephaly (HP:0007260) | 2.38255532 |
| 90 | Stomach cancer (HP:0012126) | 2.37089179 |
| 91 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.36928488 |
| 92 | Progressive inability to walk (HP:0002505) | 2.34017878 |
| 93 | Congenital hepatic fibrosis (HP:0002612) | 2.32829434 |
| 94 | Lymphopenia (HP:0001888) | 2.32804115 |
| 95 | Inflammation of the large intestine (HP:0002037) | 2.32353140 |
| 96 | Clumsiness (HP:0002312) | 2.31291632 |
| 97 | Large for gestational age (HP:0001520) | 2.29921516 |
| 98 | Urticaria (HP:0001025) | 2.29410654 |
| 99 | Basal ganglia calcification (HP:0002135) | 2.29056893 |
| 100 | Renal cortical cysts (HP:0000803) | 2.28173670 |
| 101 | Pulmonary embolism (HP:0002204) | 2.26532408 |
| 102 | Abnormal platelet volume (HP:0011876) | 2.25290580 |
| 103 | Gastrointestinal inflammation (HP:0004386) | 2.25042525 |
| 104 | Thyroiditis (HP:0100646) | 2.24971046 |
| 105 | Periodontitis (HP:0000704) | 2.24648664 |
| 106 | Chronic sinusitis (HP:0011109) | 2.22286287 |
| 107 | Thrombophlebitis (HP:0004418) | 2.22093932 |
| 108 | Gangrene (HP:0100758) | 2.22016428 |
| 109 | Chest pain (HP:0100749) | 2.21215225 |
| 110 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.19654919 |
| 111 | Hepatitis (HP:0012115) | 2.19604547 |
| 112 | Abnormality of B cell number (HP:0010975) | 2.18786011 |
| 113 | B lymphocytopenia (HP:0010976) | 2.18786011 |
| 114 | Birth length less than 3rd percentile (HP:0003561) | 2.18673161 |
| 115 | Inability to walk (HP:0002540) | 2.18094549 |
| 116 | Increased cerebral lipofuscin (HP:0011813) | 2.15472934 |
| 117 | Prolonged bleeding time (HP:0003010) | 2.15123360 |
| 118 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.14301571 |
| 119 | Cellulitis (HP:0100658) | 2.12170675 |
| 120 | Purpura (HP:0000979) | 2.10824695 |
| 121 | Bronchitis (HP:0012387) | 2.10652518 |
| 122 | Abnormality of the pons (HP:0007361) | 2.10464756 |
| 123 | Decreased central vision (HP:0007663) | 2.10349937 |
| 124 | Colitis (HP:0002583) | 2.09969542 |
| 125 | Pendular nystagmus (HP:0012043) | 2.08764772 |
| 126 | Loss of speech (HP:0002371) | 2.08682157 |
| 127 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.08567495 |
| 128 | Tetraparesis (HP:0002273) | 2.07992748 |
| 129 | Polyuria (HP:0000103) | 2.07492224 |
| 130 | Increased mean platelet volume (HP:0011877) | 2.06035800 |
| 131 | Amaurosis fugax (HP:0100576) | 2.04935930 |
| 132 | Furrowed tongue (HP:0000221) | 2.04172615 |
| 133 | Chronic obstructive pulmonary disease (HP:0006510) | 2.03204799 |
| 134 | Obstructive lung disease (HP:0006536) | 2.03204799 |
| 135 | Abnormality of DNA repair (HP:0003254) | 2.01810484 |
| 136 | Impaired platelet aggregation (HP:0003540) | 2.01173523 |
| 137 | Abnormal platelet function (HP:0011869) | 2.01173523 |
| 138 | Emphysema (HP:0002097) | 2.01098786 |
| 139 | Deep venous thrombosis (HP:0002625) | 2.00581896 |
| 140 | Progressive cerebellar ataxia (HP:0002073) | 2.00245999 |
| 141 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 1.98420088 |
| 142 | Lissencephaly (HP:0001339) | 1.96527399 |
| 143 | Asplenia (HP:0001746) | 1.96426604 |
| 144 | Polyneuropathy (HP:0001271) | 1.93101160 |
| 145 | Fair hair (HP:0002286) | 1.91705400 |
| 146 | Hypoplasia of the pons (HP:0012110) | 1.91484017 |
| 147 | Patellar aplasia (HP:0006443) | 1.87262292 |
| 148 | Sclerocornea (HP:0000647) | 1.86336792 |
| 149 | Abnormality of alanine metabolism (HP:0010916) | 1.85984573 |
| 150 | Hyperalaninemia (HP:0003348) | 1.85984573 |
| 151 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.85984573 |
| 152 | Anencephaly (HP:0002323) | 1.85383734 |
| 153 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.84351730 |
| 154 | Hypoplasia of the fovea (HP:0007750) | 1.84351730 |
| 155 | Ketosis (HP:0001946) | 1.80302411 |
| 156 | Hematochezia (HP:0002573) | 1.79369693 |
| 157 | Hypoplastic iliac wings (HP:0002866) | 1.79180658 |
| 158 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.78793671 |
| 159 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.77146712 |
| 160 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.77008620 |
| 161 | Hypothermia (HP:0002045) | 1.76080146 |
| 162 | Cerebellar dysplasia (HP:0007033) | 1.75384525 |
| 163 | Ketoacidosis (HP:0001993) | 1.74837038 |
| 164 | Decreased circulating renin level (HP:0003351) | 1.73821570 |
| 165 | Duplicated collecting system (HP:0000081) | 1.73706339 |
| 166 | Clubbing of toes (HP:0100760) | 1.73684233 |
| 167 | Abnormality of the renal collecting system (HP:0004742) | 1.73384919 |
| 168 | Sloping forehead (HP:0000340) | 1.70993331 |
| 169 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.70299754 |
| 170 | Tachypnea (HP:0002789) | 1.68823441 |
| 171 | Hemiparesis (HP:0001269) | 1.68135775 |
| 172 | Broad-based gait (HP:0002136) | 1.67466490 |
| 173 | Neoplasm of the adrenal cortex (HP:0100641) | 1.67183339 |
| 174 | Hypoalbuminemia (HP:0003073) | 1.67093099 |
| 175 | Abnormal albumin level (HP:0012116) | 1.67093099 |
| 176 | Hypoproteinemia (HP:0003075) | 1.66352431 |
| 177 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.65230733 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 6.45111410 |
| 2 | MAP4K1 | 4.55571674 |
| 3 | MAP3K14 | 3.73168745 |
| 4 | TYK2 | 3.71077186 |
| 5 | TXK | 3.60366022 |
| 6 | JAK3 | 3.29269238 |
| 7 | BMPR1B | 3.21469191 |
| 8 | TBK1 | 2.63748913 |
| 9 | IKBKE | 2.61877052 |
| 10 | FGFR4 | 2.60524725 |
| 11 | ZAP70 | 2.56042015 |
| 12 | ADRBK2 | 2.55854006 |
| 13 | KIT | 2.53506401 |
| 14 | JAK1 | 2.50000434 |
| 15 | ZAK | 2.48168737 |
| 16 | EPHB1 | 2.18096363 |
| 17 | TLK1 | 2.16770617 |
| 18 | BLK | 2.15835944 |
| 19 | MAP3K13 | 2.15372777 |
| 20 | IRAK4 | 2.14363595 |
| 21 | IKBKB | 2.09938794 |
| 22 | MAP3K12 | 1.98710548 |
| 23 | STK10 | 1.98534966 |
| 24 | PINK1 | 1.88741263 |
| 25 | GRK1 | 1.82972718 |
| 26 | TAOK3 | 1.77502849 |
| 27 | WNK4 | 1.76655002 |
| 28 | BTK | 1.72517183 |
| 29 | ITK | 1.67328505 |
| 30 | MAP4K2 | 1.65570611 |
| 31 | SYK | 1.58376403 |
| 32 | PTK6 | 1.53633044 |
| 33 | ERN1 | 1.53311411 |
| 34 | WNK3 | 1.51909613 |
| 35 | CHUK | 1.46488451 |
| 36 | KDR | 1.38802866 |
| 37 | CSF1R | 1.38670999 |
| 38 | LCK | 1.38339409 |
| 39 | MAPK13 | 1.37412443 |
| 40 | FGFR3 | 1.37345393 |
| 41 | PIM2 | 1.36306041 |
| 42 | TESK2 | 1.35961019 |
| 43 | MKNK2 | 1.34550530 |
| 44 | INSRR | 1.31164724 |
| 45 | TEC | 1.30206311 |
| 46 | CSK | 1.25984611 |
| 47 | OXSR1 | 1.25472258 |
| 48 | EIF2AK1 | 1.24609103 |
| 49 | JAK2 | 1.21955873 |
| 50 | LRRK2 | 1.19132133 |
| 51 | TGFBR2 | 1.18254239 |
| 52 | TESK1 | 1.14380363 |
| 53 | PIM1 | 1.11646663 |
| 54 | VRK1 | 1.10917636 |
| 55 | TNIK | 1.09524964 |
| 56 | GRK6 | 1.09378252 |
| 57 | HCK | 1.09327234 |
| 58 | PRKCQ | 1.08035307 |
| 59 | PTK2B | 1.06749064 |
| 60 | FLT3 | 1.04264253 |
| 61 | DAPK2 | 1.02384921 |
| 62 | NEK9 | 1.01937768 |
| 63 | EEF2K | 1.00036283 |
| 64 | IRAK1 | 0.98836681 |
| 65 | NLK | 0.95337753 |
| 66 | STK39 | 0.93178537 |
| 67 | ADRBK1 | 0.91904367 |
| 68 | EPHA3 | 0.91200948 |
| 69 | FGFR2 | 0.90425981 |
| 70 | FES | 0.90413785 |
| 71 | LYN | 0.89053644 |
| 72 | STK4 | 0.88455874 |
| 73 | BRSK2 | 0.87533855 |
| 74 | RIPK4 | 0.87409272 |
| 75 | TRIM28 | 0.87167111 |
| 76 | PAK3 | 0.86135416 |
| 77 | RPS6KA4 | 0.84334885 |
| 78 | IRAK3 | 0.83307990 |
| 79 | MAP3K7 | 0.77830913 |
| 80 | BMPR2 | 0.76755490 |
| 81 | PAK4 | 0.73037857 |
| 82 | MAP3K4 | 0.72294082 |
| 83 | SIK1 | 0.72093994 |
| 84 | MAP3K11 | 0.71919600 |
| 85 | PLK2 | 0.71362948 |
| 86 | SCYL2 | 0.68815589 |
| 87 | PKN2 | 0.68273505 |
| 88 | PIK3CG | 0.67285107 |
| 89 | MKNK1 | 0.66463709 |
| 90 | PASK | 0.66314572 |
| 91 | MAPKAPK3 | 0.65963431 |
| 92 | AKT3 | 0.65589109 |
| 93 | TRIB3 | 0.63911026 |
| 94 | MAPK11 | 0.62084578 |
| 95 | CDK4 | 0.62024998 |
| 96 | TIE1 | 0.61873347 |
| 97 | STK3 | 0.60635775 |
| 98 | CDK12 | 0.56978191 |
| 99 | EIF2AK2 | 0.55873818 |
| 100 | PLK4 | 0.54614933 |
| 101 | SIK2 | 0.53886987 |
| 102 | STK11 | 0.53870658 |
| 103 | PRKCE | 0.52040243 |
| 104 | PRKAA2 | 0.50270401 |
| 105 | MARK3 | 0.49298913 |
| 106 | CDK6 | 0.48402960 |
| 107 | DYRK2 | 0.47628280 |
| 108 | MAP2K3 | 0.47346938 |
| 109 | PLK3 | 0.46593858 |
| 110 | ACVR1B | 0.45431081 |
| 111 | CAMKK2 | 0.45250651 |
| 112 | RAF1 | 0.43639278 |
| 113 | PIK3CA | 0.43625821 |
| 114 | PKN1 | 0.43535750 |
| 115 | SGK2 | 0.42283124 |
| 116 | ARAF | 0.40588847 |
| 117 | MAPKAPK5 | 0.39820192 |
| 118 | STK38L | 0.39555157 |
| 119 | MST4 | 0.39448706 |
| 120 | EIF2AK3 | 0.38954235 |
| 121 | MYLK | 0.38788114 |
| 122 | NUAK1 | 0.38688807 |
| 123 | MAP2K6 | 0.38500875 |
| 124 | MAP3K8 | 0.38378934 |
| 125 | TRPM7 | 0.38318771 |
| 126 | MAPK15 | 0.37074636 |
| 127 | NTRK3 | 0.36264205 |
| 128 | WNK1 | 0.35923038 |
| 129 | ATM | 0.35782927 |
| 130 | PRKAA1 | 0.35553543 |
| 131 | SIK3 | 0.35505141 |
| 132 | MAP3K10 | 0.35115662 |
| 133 | NEK2 | 0.34201377 |
| 134 | RPS6KA6 | 0.34015679 |
| 135 | ABL1 | 0.33061747 |
| 136 | PRKCD | 0.32505716 |
| 137 | TGFBR1 | 0.32388917 |
| 138 | MAPKAPK2 | 0.32353742 |
| 139 | PRKCG | 0.31652722 |
| 140 | CHEK2 | 0.31531560 |
| 141 | PDK1 | 0.31255390 |
| 142 | MAP3K5 | 0.30398995 |
| 143 | EGFR | 0.28506481 |
| 144 | TNK2 | 0.27033164 |
| 145 | STK24 | 0.25587614 |
| 146 | IGF1R | 0.25150206 |
| 147 | DAPK1 | 0.24735979 |
| 148 | RPS6KA5 | 0.24195061 |
| 149 | NME2 | 0.22659458 |
| 150 | ATR | 0.22491780 |
| 151 | FYN | 0.22465817 |
| 152 | PRKCH | 0.21743077 |
| 153 | LIMK1 | 0.21118638 |
| 154 | BCKDK | 0.20834192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Allograft rejection_Homo sapiens_hsa05330 | 4.29368618 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.52430197 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.47850749 |
| 4 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 3.39984425 |
| 5 | Measles_Homo sapiens_hsa05162 | 2.62868636 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.49710079 |
| 7 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.41274874 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.40861436 |
| 9 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 2.39733318 |
| 10 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31715729 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.30224458 |
| 12 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.23498007 |
| 13 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.23152825 |
| 14 | Phototransduction_Homo sapiens_hsa04744 | 2.18659282 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.09598719 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.99389299 |
| 17 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.96745046 |
| 18 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.96104914 |
| 19 | Viral myocarditis_Homo sapiens_hsa05416 | 1.95820157 |
| 20 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.92888308 |
| 21 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.91456514 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.89794578 |
| 23 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.87047978 |
| 24 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.84015366 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.80446880 |
| 26 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.75954366 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.75210467 |
| 28 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.72383959 |
| 29 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.69513472 |
| 30 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68589790 |
| 31 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.66143744 |
| 32 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.63001333 |
| 33 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.61575327 |
| 34 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.59481134 |
| 35 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.58618250 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.58543783 |
| 37 | Influenza A_Homo sapiens_hsa05164 | 1.58543452 |
| 38 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.58420795 |
| 39 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.57851974 |
| 40 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.56610925 |
| 41 | RNA polymerase_Homo sapiens_hsa03020 | 1.51772759 |
| 42 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.44226626 |
| 43 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43384664 |
| 44 | Asthma_Homo sapiens_hsa05310 | 1.42016644 |
| 45 | Basal transcription factors_Homo sapiens_hsa03022 | 1.33532613 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.30187694 |
| 47 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.30106411 |
| 48 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.28981775 |
| 49 | Malaria_Homo sapiens_hsa05144 | 1.28357649 |
| 50 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.27654236 |
| 51 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.26978553 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.25692869 |
| 53 | Apoptosis_Homo sapiens_hsa04210 | 1.25322494 |
| 54 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.25019165 |
| 55 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.21176101 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.20269678 |
| 57 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16550808 |
| 58 | RNA degradation_Homo sapiens_hsa03018 | 1.16291271 |
| 59 | Shigellosis_Homo sapiens_hsa05131 | 1.15581500 |
| 60 | ABC transporters_Homo sapiens_hsa02010 | 1.14956529 |
| 61 | Olfactory transduction_Homo sapiens_hsa04740 | 1.13269451 |
| 62 | Pertussis_Homo sapiens_hsa05133 | 1.13098631 |
| 63 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.11455088 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 1.09284742 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07046723 |
| 66 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.06933928 |
| 67 | Tuberculosis_Homo sapiens_hsa05152 | 1.03211820 |
| 68 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02822755 |
| 69 | Hepatitis B_Homo sapiens_hsa05161 | 1.01346595 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.00888047 |
| 71 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.00880066 |
| 72 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.00814508 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99989684 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.98816058 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.96966654 |
| 76 | Protein export_Homo sapiens_hsa03060 | 0.94193541 |
| 77 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.93924532 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.92186003 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.92173932 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90604633 |
| 81 | Morphine addiction_Homo sapiens_hsa05032 | 0.89844891 |
| 82 | Nicotine addiction_Homo sapiens_hsa05033 | 0.88710052 |
| 83 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.86365474 |
| 84 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.85111470 |
| 85 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84041097 |
| 86 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.80539248 |
| 87 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74099274 |
| 88 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73263964 |
| 89 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.69542900 |
| 90 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.69258254 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.68545756 |
| 92 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68391182 |
| 93 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.66056257 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64468669 |
| 95 | Platelet activation_Homo sapiens_hsa04611 | 0.63248088 |
| 96 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.62196884 |
| 97 | Peroxisome_Homo sapiens_hsa04146 | 0.62187238 |
| 98 | Salmonella infection_Homo sapiens_hsa05132 | 0.61817780 |
| 99 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58585633 |
| 100 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57419636 |
| 101 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.56156076 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.55695567 |
| 103 | Other glycan degradation_Homo sapiens_hsa00511 | 0.55385860 |
| 104 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54630112 |
| 105 | Purine metabolism_Homo sapiens_hsa00230 | 0.53964326 |
| 106 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.53804268 |
| 107 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.52859624 |
| 108 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.52275462 |
| 109 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.52048202 |
| 110 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.51805223 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.51554220 |
| 112 | Circadian entrainment_Homo sapiens_hsa04713 | 0.50171879 |
| 113 | Retinol metabolism_Homo sapiens_hsa00830 | 0.50027322 |
| 114 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.49809134 |
| 115 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.49801833 |
| 116 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.47199863 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.46464087 |
| 118 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.45838210 |
| 119 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.45134421 |
| 120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.45060351 |
| 121 | Insulin secretion_Homo sapiens_hsa04911 | 0.45051381 |
| 122 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.41914457 |
| 123 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.41387418 |
| 124 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.40502443 |
| 125 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.40011824 |
| 126 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.39920694 |
| 127 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39763045 |
| 128 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.38435588 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.38169006 |
| 130 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37114014 |
| 131 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.37054041 |
| 132 | Histidine metabolism_Homo sapiens_hsa00340 | 0.36007640 |
| 133 | HTLV-I infection_Homo sapiens_hsa05166 | 0.35975142 |
| 134 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35119699 |
| 135 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34753706 |
| 136 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.34397869 |
| 137 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.34327224 |
| 138 | Long-term depression_Homo sapiens_hsa04730 | 0.32233605 |
| 139 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.32120358 |
| 140 | Insulin resistance_Homo sapiens_hsa04931 | 0.31421479 |
| 141 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31418481 |
| 142 | Salivary secretion_Homo sapiens_hsa04970 | 0.30571637 |
| 143 | GABAergic synapse_Homo sapiens_hsa04727 | 0.30520734 |
| 144 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.30377569 |
| 145 | Amoebiasis_Homo sapiens_hsa05146 | 0.30228484 |
| 146 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.28873086 |
| 147 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28132997 |
| 148 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.27866131 |
| 149 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.27419732 |
| 150 | DNA replication_Homo sapiens_hsa03030 | 0.27398769 |
| 151 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27048061 |
| 152 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.26616992 |
| 153 | Bile secretion_Homo sapiens_hsa04976 | 0.24489095 |
| 154 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.23658785 |
| 155 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22919316 |
| 156 | Lysine degradation_Homo sapiens_hsa00310 | 0.22806714 |

